ARTICLE | Distillery Therapeutics
Inhibiting autotaxin for stroke
July 5, 2022 9:08 PM UTC
Inhibiting the LPA-generating enzyme autotaxin could help treat stroke by protecting the penumbra from hyperexcitability damage. In patients, cerebral spinal fluid autotaxin levels were elevated up to two weeks after a stroke compared with age- and sex-matched controls, and higher autotaxin levels correlated with worse outcomes on the NIH stroke scale. ...
BCIQ Company Profiles